IMCD a global leader in the distribution and formulation of specialty chemicals and ingredients, has announced the acquisition of the personal care and pharmaceutical business of YCAM Corporation, a prominent South Korean distributor.

The transaction is expected to close in the second quarter of 2025, pending customary regulatory approvals. Following the closure, YCAM’s team and capabilities will be integrated into IMCD’s operations, with both companies aiming to leverage their combined strengths to better serve the growing demands of the personal care and pharmaceutical markets in South Korea.

Founded in 2010, YCAM Corporation specializes in distributing specialty ingredients to the cosmetics, personal care, and pharmaceutical industries. The company offers its clients technical support, formulatory advice, and access to innovative ingredients through its dedicated team and laboratory resources. YCAM partners with leading global suppliers and has built a strong reputation for its deep industry knowledge and market insight. Based in Anyang, South Korea, YCAM generated approximately KRW 26 billion (EUR 17 million) in revenue in 2023 and employs a dedicated team of 8 professionals.

Dongjoon Lee, Managing Director of IMCD South Korea, expressed enthusiasm about the acquisition, and said that it aligns with the company’s strategic goal of expanding its presence in the beauty and personal care sector. "This acquisition will be an important step in expanding our footprint in the beauty and personal care market and further enriches our life science portfolio. We are excited to welcome such a dedicated and skilled team to IMCD," Lee said.

Munkyum Kim, CEO of YCAM Corporation, also voiced optimism about the acquisition and emphasized the potential for growth and innovation under IMCD’s global business model. “I am convinced that YCAM’s extensive resources and knowledge can swiftly integrate into IMCD's global business model, enhancing its commercial and operational strength in South Korea's personal care and pharmaceuticals industries,” Kim said. “My team has been an invaluable asset to the company, and I believe they will have even more opportunities to develop and maximize their potential with IMCD.”

YCAM's strong market position in South Korea and its deep understanding of the local personal care and pharmaceutical industries make it an ideal fit for IMCD’s expansion plans. With the integration of YCAM’s resources and expertise, IMCD aims to enhance its commercial and operational capabilities, providing expanded offerings to customers in South Korea and the wider Asia-Pacific region.

About IMCD N.V.

IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients. With a presence in over 50 countries, IMCD provides innovative solutions across a variety of industries, including life sciences, food, pharmaceuticals, personal care, and performance materials.